References
- Korting HC, Kerscher MJ, Schafer-Korting M. Topical glucocorticoids with improved benefit/risk ratio: Do they exist? J Am Acad Dermatol 1992; 27(1): 87–92
- Gilbertson EO, Spellman MC, Piacquadio DJ, et al. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol 1998; 38(2 Pt 2): 318–21
- Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol 1996; 35(4): 615–9
- Wells K, Brodell RT. Topical corticosteroid ‘addiction’: a cause of perioral dermatitis. Postgrad Med 1993; 93(5): 225–30
- Smith EB, Tsehen EH. Superficial fungal infections: clinical diagnosis and laboratory confirmation. Consultant 1982: 108–16
- Elewski BE. Superficial mycoses, dermatophytoses, and selected dermatomycoses. In: Elewski BE, ed. Cutaneous fungal infections. New York: Igaku-Shoin, 1992: 43–5
- Swartz JH, Lamkins BE. A rapid, simple stain for fungi in skin, nail scrapings, and hairs. Arch Dermatol 1964; 89: 89–94
- Ive FA, Marks R. Tinea incognito. Br Med J 1968; 3(611): 149–52
- Guest PJ, Sams WM. Dermatophytes and superficial fungi. In: Sams WM, Lynch PJ. Principles and practice of dermatology. New York: Churchill Livingstone, 1990: 146–7
- Burkhart CG. Tinea incognito. (Letter) Arch Dermatol 1981; 117(10): 606
- Feder HM Jr. Tinea incognito misdiagnosed as erythema migrans. N Engl J Med 2000; 343(1): 69